United States Diabetes Devices Industry Intelligence Growth 2025-2033 | Latest Trends, Size & Forecast Insights

DataM Intelligence has released an in-depth research report on "Diabetes Devices Market Size 2025". This report delivers power-packed insights into key growth drivers, market segmentation, regional trends, CAGR forecasts, revenue performance of top players, and emerging opportunities. Gain a 360° market perspective with detailed analysis on value, volume, and future development trends your ultimate guide to spotting high-impact opportunities and staying ahead in this dynamic market.

Download Your Sample PDF Today and (Get Priority Access With a Corporate Email ID For Faster Delivery):- https://datamintelligence.com/download-sample/diabetes-devices-market?kb

FDA Approvals

Abbott FDA clears two OTC CGM systems, boosting public access to diabetes monitoring (June 2024).

Tandem Mobi insulin pump now compatible with Dexcom G7 CGM for enhanced real-time control (May 2024).

CamDiab app approved by FDA for hybrid closed-loop insulin delivery, automating glucose-based adjustments (May 2024).

Sequel receives FDA 510(k) clearance for twiist automated insulin delivery system, improving efficiency (March 2024).

First OTC continuous glucose monitor cleared by FDA, empowering users with autonomous glucose management (March 2024).

Tandem Diabetes Care launches Tandem Mobi, the smallest and most durable automated insulin delivery system (Feb 2024).

List of Top Key Players:

F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE, Insulet Corporation, Nipro Corporation, Johnson & Johnson Services, Inc., Senseonics, Inc., Tandem Diabetes Care, Inc. and among others.

Key industry Developments

Popular home glucose monitors like Roche's Accu-Chek and LifeScan's OneTouch are favored for ease, speed, and affordability; in 2024, Medtronic launched FDA-cleared InPen Smart MDI and Simplera CGM, while Smart Meter updated its iGlucose system used by 200,000+ patients.

Over 38M Americans (11.6%) have diabetes, relying on devices like CGMs and insulin pumps. North America hosts top manufacturers-Medtronic, Dexcom, Abbott, Roche, J&J-driving innovations. In July 2024, Roche got CE Mark for Accu-Chek SmartGuide CGM, and in August 2024, Abbott partnered with Medtronic to integrate CGM with automated insulin delivery systems.

Forecast Growth Projection:

Global Diabetes Devices Market Positioned for Strong Growth 2025-2033, Building on the steady momentum of 2024, the market is poised for remarkable expansion as leading players embrace innovative technologies and strategic advancements. This evolving landscape is unlocking lucrative opportunities for businesses to invest, scale, and stay ahead in an increasingly competitive and fast-moving market.

Market Research Process:

The Diabetes Devices Market research report by DataM Intelligence combines extensive Primary and Secondary research to provide powerful, in-depth insights. It examines key market drivers such as regulatory frameworks, evolving market conditions, competitive dynamics, historical trends, and breakthrough technologies, while spotlighting emerging innovations and potential challenges. This all-inclusive analysis uncovers high-growth opportunities and highlights possible barriers, equipping businesses to tackle market volatility and capture new avenues for success.

Buy Now & Get Instant Access to 360° Market Intelligence:- https://www.datamintelligence.com/buy-now-page?report=diabetes-devices-market

Market Segments:

The blood glucose monitoring segment leads the diabetes devices market, growing from US$11.99B in 2022 to US$12.78B in 2023.

Global Growth Regions:

Asia-Pacific leads diabetes device growth, driven by rising prevalence-over 60% of global cases, mainly in China and India. Advanced CGMs, insulin pumps, and smart pens are increasingly adopted. In November 2024, Beurer India launched the GL 22 Blood Glucose Monitor, offering 7-90 day trend tracking aligned with HbA1c for improved diabetes management.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Key Drivers

Global diabetes prevalence hit 536.6M adults in 2021 and is expected to reach 642.8M by 2030, driving device demand (IDF).

FDA cleared Senseonics' Eversense 365, the world's first 1-year CGM, for adults with Type 1 & 2 diabetes (Sept 2024).

Embecta Corp. received FDA 510(k) clearance for a tubeless patch insulin pump with 300-unit reservoir for T1D & T2D (Sept 2024).

Dexcom G6 CGM costs $366 per transmitter (90 days) and ~$8,000 annually out-of-pocket, limiting adoption in low-income regions.

High device costs, e.g., CGMs and insulin pumps, remain a major barrier despite advanced features and improved patient adherence.

Benefits of the Report:

Chapter 1: Opens the report with a comprehensive market overview, highlighting key segments by region, product type, and application. It presents a clear snapshot of market size, growth potential by segment, and both short- and long-term outlook.

Chapter 2: Showcases the most impactful insights, uncovering the emerging trends and disruptive forces shaping the industry's future.

Chapter 3: Delivers an in-depth competitive landscape analysis of the Diabetes Devices market, covering revenue shares, strategic moves, and the latest mergers & acquisitions.

Chapter 4: Features detailed profiles of leading players, including their revenue streams, profit margins, product portfolios, and key milestones.

Chapters 5 & 6: Present a granular breakdown of regional and country-level revenue performance, offering a precise view of market size, opportunities, and development prospects worldwide.

Chapter 7: Analyzes market segmentation by product type, revealing the growth potential of each category and spotlighting high-impact.

Chapter 8: Examines application-based market growth, identifying the fastest-expanding sectors and lucrative opportunities for expansion.

Chapter 9: Maps the entire industry supply chain, providing insights into upstream and downstream activities for a complete market perspective.

Chapter 10: Concludes with key findings and actionable takeaways, guiding stakeholders toward strategic decisions and future growth opportunities.

Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/diabetes-devices-market?kb

Q1: How Large is the Diabetes Devices Market?

A: The Diabetes Devices Market was valued at US$ 33.4 billion in 2024 and is expected to experience substantial growth, reaching US$ 64.8 billion by 2033.

Q2: How fast is the Diabetes Devices Market growing?

A: The Market is experiencing strong growth and is projected to expand at a CAGR of 7.7% from 2025 to 2033.

Q3: Which Region Leads Diabetes Devices Market growth?

A: North America leads the diabetes devices market, growing from US$11.10B in 2022 to US$11.80B in 2023.

Try DataM Subscription Services free for 2 days - Get Started@ https://www.datamintelligence.com/reports-subscription?kb

Make smarter moves with real-time competitor insights, strategic forecasts, and global investment trends-get it all now!

Access your Subscription Dashboard today@ https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.